Skip to content

Comparison of the Effectiveness of Three Different Treatment Methods in Myofascial Pain Patients

Comparison of the Effectiveness of Three Different Treatment Methods in Myofascial Pain Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03400462
Enrollment
90
Registered
2018-01-17
Start date
2016-07-01
Completion date
2017-12-12
Last updated
2018-01-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Temporomandibular Disorder

Keywords

Dry needling, occlusal splint, NSAID, nimesulide

Brief summary

The aim of this study was to compare the effectiveness of myofascial pain treatment methods.

Detailed description

Three different metoda were taken into account: dry needling, occlusal sprint therapy and NSAID therapy.

Interventions

DRUGNSAID

Nimesulide has anti-inflammatory and analgesic properties. Like other NSAIDs it inhibits the action of COX . If prostaglandins can not be further synthesized, so there is no factor able to excite local nociceptors. According to t must be taken regularly for a minimum 2 weeks to achieve appropriate blood concentration.

The stabilization appliance used in this study was a removable device for maxillary arch, made of hard acrylic. Appliance was fitted over occlusal and incisal surfaces of the teeth and precisely contacted with the teeth of opposing arch. It provided canine disocclusion of the posterior teeth during eccentric movements.

OTHERdry needling

Equipment: acupuncture needle 0,6\*13 e.g. Dragon Medical Device, Visits schedule:( 1st visit - Day 1st , 2nd visit- 7 days after the 1st, 3rd visit- 7 days after the 2nd)

Sponsors

Pomeranian Medical University Szczecin
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* pain localized in the TMJ or in the preauricular area. * no other analgesic treatment in the area of head and neck during last 12 months

Exclusion criteria

* inflammation in the oral cavity that emerge as a myofascial pain * earlier splint therapy * pharmacotherapy e.g oral contraception, hormone replacement therapy, -antidepressants * systemic diseases e.g. rheumatic, metabolic * lack of stability in the masticatory organ motor system * masticatory organ injury

Design outcomes

Primary

MeasureTime frameDescription
Visual Analogue Scale6 monthsIt is a continuous scale comprised of a horizontal line, usually 10 cm in length. no pain (score of 0) and pain as bad as it could be (score of 10)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026